Treatment of early Parkinson's disease
Dickerson, L.M.; Young, S.E.; Simpson, W.M.; Nashelsky, J.
American Family Physician 72(3): 497-500
2005
ISSN/ISBN: 0002-838X PMID: 16100865 Document Number: 585508
Document emailed within 1 workday
Related Documents
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234Stacy, M.; Brownlee, H.J. 1996: Treatment options for early Parkinson's disease American Family Physician 53(4): 1281-1287
Marttila, R. 2004: Which drug to use for the initiation of treatment for early Parkinson's disease Duodecim; Laaketieteellinen Aikakauskirja 120(5): 587-590
Broussolle, E. 2000: Dopa-therapy in the treatment of early stage Parkinson's disease Revue Neurologique (Paris) 156(2 Part 2): 91-97
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41
Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238
Suwantamee, J.; Nidhinandana, S.; Srisuwananukorn, S.; Laptikultham, S.; Pisarnpong, A.; Chankrachang, S.; Bundhukul, A. 2004: Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study Journal of the Medical Association of Thailand 87(11): 1293-1300
Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality Bmj 317(7172): 1586-1587
Petit, H. 1984: Early or late dopa therapy in Parkinson's disease Presse Medicale 13(36): 2213
Katunina, E.A.; Titova, N.V.; Avakian, G.N. 2010: Methods of diagnosis early stage Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(12): 112-118
Csanda, E.; Tárczy, M. 1987: Selegiline in the early and late phases of Parkinson's disease Journal of Neural Transmission. Supplementum 25: 105-113
García de Yébenes, J.; Bazán, E.; Mena, M.A.; Muradas, V.; Reiriz, J.; Romero, J.; González-Elipe, J. 1986: Clinical and biochemical aspects of early-onset Parkinson's disease Revista Clinica Espanola 178(7): 343-346
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Gönül, A.S.; Aksu, M. 1999: SSRI-induced parkinsonism may be an early sign of future Parkinson's disease Journal of Clinical Psychiatry 60(6): 410
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Atsumi, M.; Li, Y.; Tomiyama, H.; Sato, K.; Hattori, N. 2006: A 62-year-old woman with early-onset Parkinson's disease associated with the PINKi gene deletion Rinsho Shinkeigaku 46(3): 199-202
Bode, M. 2009: Dopamine agonist therapy in early Parkinson's disease. a survey of a Cochrane review Ugeskrift for Laeger 171(41): 2996-2999
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Mu, Y.-L.; Chen, H.-B.; Li, S.-H.; Cai, X.-J.; Su, W.; Wang, X.-D. 2008: Chinese characters morphological and phonetic working memory impairment in early Parkinson disease Zhonghua Yi Xue Za Zhi 88(7): 438-441